STOCKHOLM, SWEDEN (UroToday.com) - Presented by D. Heinrich,1 C. Parker,2 M. Shan,3 S. Wilhelm,3 M. Wahba,3 J. Garcia-Vargas,3 C.G. O’Bryan-Tear,4 O. Sartor5 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Akershus University Hospital, Lørenskog, Norway; 2The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK; 3Bayer HealthCare, Whippany, NJ, USA; 4Algeta ASA, Oslo, Norway; 5Tulane University Cancer Center, New Orleans, LA, USA
Click HERE to read an exclusive report by a UroToday medical writer